Pfizer - Recruiting 18 years or older. - An Open Label, Non-Interventional Study of the Safety of Desvenlafaxine Succinate (Pristiq) in the Treatment of Major Depressive Disorder (MDD) and Vasomotor Symptoms (VMS) Associated With Menopause in Filipino Adult Patients: a Post Marketing Surveillance Study.
Ferring Pharmaceuticals - Recruiting 18 years to 40 years. - A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Two Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism.
Fred Hutchinson Cancer Research Center - Recruiting 40 years to 65 years. - Menopausal Strategies: Finding Lasting Answers for Symptoms and Health (MsFLASH) 04: A Pilot Trial of Telephone-Based Cognitive-Behavioral Therapy for Midlife Women With Menopause-related Sleep Disturbance.
Hospital de Clinicas de Porto Alegre - Recruiting 18 years or older. - Transcranial Direct Current Stimulation (tDCS) in Vasomotor Symptoms of Menopause: Blind Sham Controlled Randomized Clinical Trial.
Laboratorios Casen-Fleet S.L.U. - Recruiting 45 years to 60 years. - Randomized, Double-blind, Placebo-controlled Clinical Trial, to Evaluate the Efficacy and Tolerability of the Combination of Soy Isoflavones and Red Clover Extract (FITOGYN) in the Treatment of the Hot Flushes in Menopausal Women..
Soy isoflavones (Glycine max L) and red clover extract (Trifolium pretense L); Placebo